Department of Experimental and Clinical Medicine, Section of Pharmacology and BioPharmaNet TransLab, University of Ferrara, 44100 Ferrara, Italy.
J Neural Transm (Vienna). 2010 May;117(5):593-7. doi: 10.1007/s00702-010-0389-4. Epub 2010 Mar 31.
Previous studies have indicated that cocaine binding sites contain both high- and low-affinity binding components and have actions not related to dopamine uptake inhibition. Therefore, it has been studied if concentrations of cocaine in the range of 0.1-100 nM can affect not only dopamine uptake but also the quinpirole-induced inhibition of the K(+)-evoked [(3)H]-dopamine efflux from rat striatal synaptosomes. It was found that quinpirole-induced inhibition of K(+)-evoked [(3)H]-dopamine efflux was significantly enhanced by cocaine at 1 and 10 nM but not at 0.1 nM with cocaine alone being inactive and 1 nM cocaine lacking effects on [(3)H]-dopamine uptake in rat striatal synaptosomes. The results indicate the existence of a novel allosteric agonist action of cocaine in low concentrations, not affecting dopamine uptake, at striatal D(2) autoreceptors modulating striatal dopamine transmission.
先前的研究表明,可卡因结合位点包含高亲和性和低亲和性结合成分,并且具有与多巴胺摄取抑制无关的作用。因此,研究人员研究了 0.1-100 nM 范围内的可卡因浓度是否不仅能影响多巴胺摄取,还能影响喹吡罗诱导的大鼠纹状体突触小体中 K(+)-诱发的[(3)H]-多巴胺外排的抑制作用。结果发现,1 nM 和 10 nM 的可卡因显著增强了喹吡罗诱导的 K(+)-诱发的[(3)H]-多巴胺外排的抑制作用,但 0.1 nM 的可卡因则没有作用,单独使用可卡因没有活性,且 1 nM 的可卡因对大鼠纹状体突触小体中[(3)H]-多巴胺摄取没有影响。结果表明,在低浓度下可卡因存在一种新型的变构激动剂作用,这种作用不影响多巴胺摄取,而是通过调节纹状体多巴胺传递来作用于纹状体 D2 自身受体。